- Home
- TRMK vs KOD Comparison
TRMK vs KOD Comparison
Compare TRMK & KOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TRMK | KOD |
|---|---|---|
| Founded | 1889 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5B | 2.3B |
| IPO Year | 1994 | 2018 |
Fundamental Metrics
Financial Performance| Metric | TRMK | KOD |
|---|---|---|
| Price | $42.59 | $40.63 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 7 |
| Target Price | ★ $43.50 | $35.43 |
| AVG Volume (30 Days) | 364.6K | ★ 1.5M |
| Earning Date | 04-28-2026 | 05-13-2026 |
| Dividend Yield | ★ 2.35% | N/A |
| EPS Growth | ★ 1.93 | N/A |
| EPS | ★ 3.70 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $9.49 | N/A |
| Revenue Next Year | $5.17 | N/A |
| P/E Ratio | $11.51 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $29.81 | $1.92 |
| 52 Week High | $45.43 | $45.60 |
Technical Indicators
Market Signals| Indicator | TRMK | KOD |
|---|---|---|
| Relative Strength Index (RSI) | 54.85 | 67.83 |
| Support Level | $36.46 | $21.82 |
| Resistance Level | $43.29 | N/A |
| Average True Range (ATR) | 0.93 | 3.46 |
| MACD | 0.17 | 1.97 |
| Stochastic Oscillator | 86.87 | 79.80 |
Price Performance
Historical ComparisonAbout TRMK Trustmark Corporation
Trustmark Corp is a bank holding company. Through its subsidiaries, the company operates as a financial services organization providing banking and other financial solutions in Alabama, Florida, Mississippi, Tennessee, and Texas. Its principal products and services include Commercial Banking, Consumer Banking, Mortgage Banking, Insurance, Wealth Management and Trust Services, and others. The company is managed along two operating segments: General Banking and Wealth Management. The General Banking segment, which generates the majority of the revenue, provides all traditional banking products and services, including loan deposits, and also consists of internal operations.
About KOD Kodiak Sciences Inc
Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is BLA, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD. The pipeline products of the company include Tarcocimab tedromer, KSI-501, and KSI-101.